In Vitro Diagnostics Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the In Vitro Diagnostics Industry Market Size Be by 2025?
Recent years have seen a swift expansion in the size of the in vitro diagnostics market. Its growth is projected to escalate from $121.96 billion in 2024 to $136.55 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this increase during the historic period include the advancement of automated analyzers and molecular diagnostics, an aging populace, outbreaks of diseases, healare legislation, and the advent of personalized medicine.

What's the Long-Term Growth Forecast for the In Vitro Diagnostics Market Size Through 2029?
Expectations are high for the in vitro diagnostics market as it is projected to experience a swift expansion in the foroming years. The market size is anticipated to balloon to $214.88 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.0%. Volume boost in the forecast period can be credited to a variety of factors such as precision medicine, point-of-care testing, digital health and data analytics, and preparedness for pandemics. The forecast period will also see major trends like technological advancements, integration of digital health, personalized diagnostics, home testing kits, and molecular diagnostics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

What Are the Key Growth Drivers Fueling the In Vitro Diagnostics Market Expansion?
The surging interest in self-administered testing kits is set to boost the expansion of the in vitro diagnostics market. Such kits provide non-doctor administered medical tests designed for personal use. These self-administrated kits augment accessibility by allowing people to conduct diagnostic evaluations at their homes, providing comfort and likely augmenting the need for testing, especially for conditions that have not been previously diagnosed. For example, The Centers for Disease Control and Prevention, a US national public health agency, reported in April 2022, a notable surge in the utilization of home-based COVID-19 tests among U.S. adults aged 18 and above from the Delta-predominant phase (August to December 2021) to the Omicron-predominant era (December to March 2022). The usage of at-home tests among respondents who showed COVID-19 symptoms rose from 5.7% to 20.1%. Hence, the surging popularity of self-administered test kits is anticipated to boost the in vitro diagnostics market growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the In Vitro Diagnostics Market?
Leading enterprises in the in vitro diagnostics industry are channeling their efforts towards unveiling innovative products like the Cobas pulse system to enhance their market profitability. The Cobas pulse system is a next-gen professional blood glucose management solution integrated with mobile digital health functionality aimed at optimizing patient care. For example, Roche Diagnostics, a US-based company specializing in the development of groundbreaking products and services for disease prevention, diagnosis, monitoring, screening, and treatment, introduced the Cobas pulse system to the market in January 2022. The Cobas pulse system is a portable instrument equipped with an advanced glucose test strip reader, a camera, and a touchscreen to capture additional diagnostic data. With its user-friendly interface, the system offers easy implementation and features time-saving functions to streamline procedures and improve workflows.

How Is the In Vitro Diagnostics Market Segmented?
The in vitro diagnostics market covered in this report is segmented -

1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment
2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users
3) By Type of Expenditure: Public, Private
4) By Product: Instruments/Equipment, Disposables

Subsegments:
1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing
2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)
3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing
4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices
5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems
6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers
7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters
8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp

Which Companies Are Leading the Charge in In Vitro Diagnostics Market Innovation?
Major companies operating in the in vitro diagnostics market include Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, inson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

Which Regions Are Leading the Global In Vitro Diagnostics Market in Revenue?
North America was the largest region in the global in-vitro diagnostics market in 2024. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13065

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.